Fluvoxamine

ATC N06AB08 · 8 markets · 185 records

Fluvoxamine 8 markets · 185 records Forms

CN 46 records · 2 strengths

  • 50 mgtablet兰释马来酸氟伏沙明__mah__:上海理想制药有限公司、__mah__:丽珠集团丽珠制药厂、__mah__:安徽省先锋制药有限公司、__mah__:山东京卫制药有限公司、__mah__:成都倍特药业股份有限公司、__mah__:昆山龙灯瑞迪制药有限公司、__mah__:桂林华信制药有限公司、__mah__:江苏万高药业股份有限公司 +6 also in US·GB·AU +3
  • 100 mgtablet兰释马来酸氟伏沙明__mah__:安徽省先锋制药有限公司、__mah__:昆山龙灯瑞迪制药有限公司、__mah__:石家庄四药有限公司 also in US·GB·AU +3

US 44 records · 5 strengths

  • 50 mgtabletNo trade name also in CN·GB·AU +3
  • 100 mgtabletNo trade name also in CN·GB·AU +3
  • 25 mgtabletNo trade name
  • 150 mgcapsule · extended-releaseNo trade name
  • 100 mgcapsule · extended-releaseNo trade name

GB 32 records · 3 strengths

AU 15 records · 3 strengths

Records without a stated strength · 1 APO-Fluvoxamine、Faverin 50mg tablets、FLUVOXAMINE-WGR、LUVOX、Movox +2

CA 8 records · 2 strengths

TW 7 records · 4 strengths

ES 4 records · 2 strengths

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.